Skip to main content

Market Overview

Moderna Inks 25M COVID-19 Shots Supply Pact With Australia

Share:
Moderna Inks 25M COVID-19 Shots Supply Pact With Australia
  • Moderna Inc (NASDAQ: MRNA) has announced a new agreement to supply 25 million doses of its COVID-19 vaccine to Australia.
  • The deal includes 10 million doses of the company's mRNA-1273 vaccine delivered this year and 15 million doses of its variant booster vaccine candidate to be delivered in 2022.
  • The agreement is subject to the approval of mRNA-1273 and the booster vaccine candidate by Australia's Therapeutic Goods Administration.
  • Price Action: MRNA shares are down 0.75% at $157.84 during the premarket session on the last check Wednesday.
 

Related Articles (MRNA)

View Comments and Join the Discussion!

Posted-In: Australia BriefsBiotech Government News Health Care Contracts General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com